[HTML][HTML] Thoracic and cardiovascular surgeries in Japan during 2018: annual report by the Japanese Association for Thoracic Surgery
Committee for Scientific Affairs, The Japanese … - General thoracic and …, 2021 - Springer
The Japanese Association for Thoracic Surgery has conducted annual surveys of thoracic
surgery throughout Japan since 1986 to determine statistics pertaining to the number of …
surgery throughout Japan since 1986 to determine statistics pertaining to the number of …
A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats
H Ueda, T Nakamura, K Matsumoto… - Cardiovascular …, 2001 - academic.oup.com
Objective: Cardiotrophic growth factors with anti-cell death actions on cardiac myocytes
have gained attention for treatment of patients with myocardial infarction. Hepatocyte growth …
have gained attention for treatment of patients with myocardial infarction. Hepatocyte growth …
Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis
M Okumura, Y Fujii, H Shiono, M Inoue… - General thoracic and …, 2008 - Springer
Thymoma and thymic carcinoma are the representative tumors arising from the thymic
epithelium. Thymoma is well known for association with autoimmune diseases including …
epithelium. Thymoma is well known for association with autoimmune diseases including …
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
T Ueki, Y Kaneda, H Tsutsui, K Nakanishi, Y Sawa… - Nature medicine, 1999 - nature.com
Liver cirrhosis is the irreversible end result of fibrous scarring and hepatocellular
regeneration, characterized by diffuse disorganization of the normal hepatic structure of …
regeneration, characterized by diffuse disorganization of the normal hepatic structure of …
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
R Morishita, T Sugimoto, M Aoki, I Kida, N Tomita… - Nature medicine, 1997 - nature.com
The transcriptional factor nuclear factor-κ B (NF κ B) plays a pivotal role in the coordinated
trans-activation of cytokine and adhesion molecule genes that might be involved in …
trans-activation of cytokine and adhesion molecule genes that might be involved in …
Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model
Background—Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) are
a promising source of cells for regenerating myocardium. However, several issues …
a promising source of cells for regenerating myocardium. However, several issues …
[HTML][HTML] Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
T Nakamura, S Mizuno, K Matsumoto… - The Journal of …, 2000 - Am Soc Clin Investig
Using a rat model of ischemia/reperfusion injury, we demonstrate here that HGF is
cardioprotective due to its antiapoptotic effect on cardiomyocytes. Following transient …
cardioprotective due to its antiapoptotic effect on cardiomyocytes. Following transient …
JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure―digest version―
H Tsutsui, M Isobe, H Ito, K Okumura, M Ono… - Circulation …, 2019 - jstage.jst.go.jp
Heart Failure Society (JHFS). The working committee for this project includes members and
collaborators involved in the previous versions of the heart failure guidelines and members …
collaborators involved in the previous versions of the heart failure guidelines and members …
Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case
Y Sawa, S Miyagawa, T Sakaguchi, T Fujita… - Surgery today, 2012 - Springer
Dilated cardiomyopathy (DCM) is a heart muscle disease characterized by progressive heart
failure, and is a leading cause of mortality and morbidity. Recently, cellular therapy for end …
failure, and is a leading cause of mortality and morbidity. Recently, cellular therapy for end …
[HTML][HTML] Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets
IA Memon, Y Sawa, N Fukushima, G Matsumiya… - The Journal of thoracic …, 2005 - Elsevier
OBJECTIVES: Autologous skeletal myoblast cell transplantation by means of the injection
method is subject to the loss of intercellular communication, extracellular matrix, and cell …
method is subject to the loss of intercellular communication, extracellular matrix, and cell …